$1.11 Billion is the total value of First Light Asset Management, LLC's 74 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 16.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ATRC | Buy | ATRICURE INC | $60,477,913 | -6.2% | 1,459,057 | +0.5% | 5.44% | -9.0% |
| NEO | Buy | NEOGENOMICS INC | $46,988,859 | +89.6% | 2,698,958 | +0.6% | 4.23% | +84.0% |
| ATEC | Buy | ALPHATEC HLDGS INC | $45,928,350 | +27.1% | 2,944,125 | +0.6% | 4.14% | +23.3% |
| OFIX | New | ORTHOFIX MED INC | $44,403,764 | – | 2,650,971 | +100.0% | 4.00% | – |
| KRTX | Buy | KARUNA THERAPEUTICS INC | $44,261,127 | +36.8% | 243,675 | +48.0% | 3.98% | +32.7% |
| SIBN | Buy | SI-BONE INC | $41,586,550 | +45.2% | 2,114,212 | +0.4% | 3.74% | +40.9% |
| PLRX | Buy | PLIANT THERAPEUTICS INC | $37,914,416 | +85.4% | 1,425,354 | +34.7% | 3.41% | +79.9% |
| Buy | PARAGON 28 INC | $34,787,619 | +47.2% | 2,037,939 | +64.8% | 3.13% | +42.8% | |
| PFMT | Buy | PERFORMANT FINL CORP | $27,916,377 | +4.7% | 8,210,699 | +11.1% | 2.51% | +1.6% |
| CRNX | Buy | CRINETICS PHARMACEUTICALS IN | $26,003,148 | +6.9% | 1,619,125 | +21.8% | 2.34% | +3.7% |
| TMDX | Buy | TRANSMEDICS GROUP INC | $25,590,076 | +56.4% | 337,912 | +27.5% | 2.30% | +51.7% |
| KROS | Buy | KEROS THERAPEUTICS INC | $25,362,263 | -10.8% | 593,964 | +0.3% | 2.28% | -13.5% |
| TNDM | Buy | TANDEM DIABETES CARE INC | $23,926,803 | -9.2% | 589,185 | +0.5% | 2.15% | -11.9% |
| HCAT | Buy | HEALTH CATALYST INC | $23,110,299 | +87.1% | 1,980,317 | +70.4% | 2.08% | +81.6% |
| BLU | Buy | BELLUS HEALTH INC NEW | $21,746,830 | +12.2% | 3,020,393 | +28.1% | 1.96% | +8.9% |
| BCYC | Buy | BICYCLE THERAPEUTICS PLC | $14,874,707 | -27.8% | 699,328 | +0.4% | 1.34% | -30.0% |
| OPRX | Buy | OPTIMIZERX CORP | $14,789,921 | +143.7% | 1,010,931 | +179.8% | 1.33% | +136.6% |
| CUTR | Buy | CUTERA INC | $13,460,282 | -46.3% | 569,868 | +0.5% | 1.21% | -47.9% |
| INSM | Buy | INSMED INC | $12,802,555 | -14.4% | 750,883 | +0.3% | 1.15% | -17.0% |
| TCMD | New | TACTILE SYS TECHNOLOGY INC | $11,494,000 | – | 700,000 | +100.0% | 1.04% | – |
| REPH | Buy | SOCIETAL CDMO INC | $10,611,075 | -16.9% | 8,916,870 | +4.0% | 0.96% | -19.4% |
| XENE | New | XENON PHARMACEUTICALS INC | $10,001,301 | – | 279,444 | +100.0% | 0.90% | – |
| RARE | Buy | ULTRAGENYX PHARMACEUTICAL IN | $9,454,658 | -12.9% | 235,777 | +0.6% | 0.85% | -15.6% |
| ABCM | Buy | ABCAM PLC | $5,110,910 | -13.5% | 379,711 | +0.0% | 0.46% | -16.1% |
| GH | Buy | GUARDANT HEALTH INC | $4,801,567 | -13.8% | 204,845 | +0.0% | 0.43% | -16.4% |
| MIRO | Buy | MIROMATRIX MED INC | $3,754,222 | +134.8% | 2,234,656 | +318.0% | 0.34% | +128.4% |
| CSTL | Buy | CASTLE BIOSCIENCES INC | $3,671,961 | -3.5% | 161,618 | +0.0% | 0.33% | -6.2% |
| New | STEVANATO GROUP S P A | $2,987,720 | – | 115,356 | +100.0% | 0.27% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ATRICURE INC | 40 | Q3 2023 | 9.7% |
| NEOGENOMICS INC | 40 | Q3 2023 | 10.6% |
| SANOFI-SYNTHELABO | 40 | Q3 2023 | 1.9% |
| JOHNSON & JOHNSON | 40 | Q3 2023 | 0.3% |
| PFIZER INC | 39 | Q2 2023 | 0.9% |
| BIOMARIN PHARMACEUTICAL INC | 36 | Q3 2023 | 1.6% |
| OMNICELL INC | 33 | Q3 2023 | 7.7% |
| QUIDEL CORP | 33 | Q4 2021 | 3.7% |
| NOVARTIS AG-SPONSORED ADR | 33 | Q3 2023 | 0.4% |
| MODEL N INC | 30 | Q3 2023 | 9.0% |
View First Light Asset Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| REATA PHARMACEUTICALS INC | May 15, 2023 | 1,290,193 | 3.9% |
| Axogen, Inc. | February 03, 2023 | 1,942,270 | 4.6% |
| MODEL N, INC. | February 03, 2023 | 1,845,134 | 4.9% |
| MEI Pharma, Inc.Sold out | May 31, 2022 | 0 | 0.0% |
| PROTHENA CORP PUBLIC LTD CO | March 01, 2022 | 1,805,038 | 3.9% |
| Intersect ENT, Inc. | February 14, 2022 | 1,375,210 | 4.1% |
| SeaSpine Holdings Corp | February 14, 2022 | 6,847,707 | 18.8% |
| Oxford Immunotec Global PLCSold out | February 10, 2021 | 0 | 0.0% |
| ENDOLOGIX INC /DE/ | February 14, 2020 | 816,236 | 4.6% |
| Nuvectra CorpSold out | February 14, 2020 | 0 | 0.0% |
View First Light Asset Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D/A | 2024-04-09 |
| 4 | 2024-04-08 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
View First Light Asset Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.